{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:10:12Z","timestamp":1779358212761,"version":"3.51.4"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1007\/s11894-005-0018-9","type":"journal-article","created":{"date-parts":[[2007,5,19]],"date-time":"2007-05-19T22:37:27Z","timestamp":1179614247000},"page":"264-271","source":"Crossref","is-referenced-by-count":73,"title":["Symptom overlap and comorbidity of irritable bowel syndrome with other conditions"],"prefix":"10.1007","volume":"7","author":[{"given":"Christine L.","family":"Frissora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth L.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"Suppl","key":"18_CR1","first-page":"S7","volume":"97","author":"LJ Brandt","year":"2002","unstructured":"Brandt LJ, Bjorkman D, Fennerty MB, et al.: Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol 2002, 97(Suppl):S7-S26.","journal-title":"Am J Gastroenterol"},{"key":"18_CR2","unstructured":"Camilleri M: Gastrointestinal motility disorders. http:\/\/ www.medscape.com\/viewarticle\/479189. Accessed 11\/8\/04."},{"key":"18_CR3","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1007\/BF02093603","volume":"41","author":"G Bassotti","year":"1996","unstructured":"Bassotti G, Stanghellini V, Chiarioni G, et al.: Upper gastrointestinal motor activity in patients with slow-transit constipation. Further evidence for an enteric neuropathy. Dig Dis Sci 1996, 41:1999\u20132005.","journal-title":"Dig Dis Sci"},{"key":"18_CR4","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.3748\/wjg.v9.i10.2293","volume":"9","author":"P Portincasa","year":"2003","unstructured":"Portincasa P, Moschetta A, Baldassarre G, et al.: Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome. World J Gastroenterol 2003, 9:2293\u20132299.","journal-title":"World J Gastroenterol"},{"key":"18_CR5","unstructured":"Zelnorm (tegaserod maleate) tablets. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2004."},{"issue":"Suppl","key":"18_CR6","first-page":"S252","volume":"7","author":"MD Crowell","year":"2001","unstructured":"Crowell MD: The role of serotonin in the pathophysiology of irritable bowel syndrome. Am J Manag Care 2001, 7(Suppl):S252-S260.","journal-title":"Am J Manag Care"},{"key":"18_CR7","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/j.1572-0241.2004.30040.x","volume":"99","author":"M Corsetti","year":"2004","unstructured":"Corsetti M, Caenepeel P, Fischler B, et al.: Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia. Am J Gastroenterol 2004, 99:1152\u20131159.","journal-title":"Am J Gastroenterol"},{"key":"18_CR8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2036.2004.02184.x","volume":"20","author":"F Cremonini","year":"2004","unstructured":"Cremonini F, Talley NJ: Review article: The overlap between functional dyspepsia and irritable bowel syndrome: a tale of one or two disorders? Aliment Pharmacol Ther 2004, 20:40\u201349.","journal-title":"Aliment Pharmacol Ther"},{"key":"18_CR9","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1053\/j.gastro.2004.03.013","volume":"126","author":"MD Coates","year":"2004","unstructured":"Coates MD, Mahoney CR, Linden DR, et al.: Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 2004, 126:1657\u20131664.","journal-title":"Gastroenterology"},{"key":"18_CR10","first-page":"55","volume":"5","author":"MD Crowell","year":"2004","unstructured":"Crowell MD, Shetzline MA, Moses PL, et al.: Enterochromaffin cells and 5-HT signaling in the pathophysiology of disorders of gastrointestinal function. Curr Opin Investig Drugs 2004, 5:55\u201360.","journal-title":"Curr Opin Investig Drugs"},{"key":"18_CR11","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1053\/gast.2002.37095","volume":"123","author":"DA Drossman","year":"2002","unstructured":"Drossman DA, Camilleri M, Mayer EA, Whitehead WE: AGA technical review on irritable bowel syndrome. Gastroenterology 2002, 123:2108\u20132131.","journal-title":"Gastroenterology"},{"key":"18_CR12","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1053\/gast.1997.v112.agast972120","volume":"112","author":"DA Drossman","year":"1997","unstructured":"Drossman DA, Whitehead WE, Camilleri M: Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997, 112:2120\u20132137.","journal-title":"Gastroenterology"},{"key":"18_CR13","doi-asserted-by":"crossref","first-page":"S280","DOI":"10.1016\/S0002-9270(02)05337-6","volume":"97","author":"APS Hungin","year":"2002","unstructured":"Hungin APS, Tack J, Mearin F, et al.: Irritable bowel syndrome (IBS): prevalence and impact in the USA: the truth in IBS (TIBS) survey. Am J Gastroenterol 2002, 97:S280-S281.","journal-title":"Am J Gastroenterol"},{"key":"18_CR14","unstructured":"International Foundation for Functional Gastrointestinal Disorders (IFFGD): Travel tips help IBS sufferers enjoy their summer vacations. http:\/\/www.aboutibs.org\/publications\/travel\/ 04.html.May 25, 2004."},{"key":"18_CR15","first-page":"S268","volume":"7","author":"R Martin","year":"2001","unstructured":"Martin R, Barron JJ, Zacker C: Irritable bowel syndrome: toward a cost-effective management approach. Am J Manag Care 2001, 7:S268-S275.","journal-title":"Am J Manag Care"},{"key":"18_CR16","volume-title":"The Burden of Gastrointestinal Diseases","author":"American Gastroenterological Association","year":"2001","unstructured":"American Gastroenterological Association: The Burden of Gastrointestinal Diseases. Bethesda, MD: American Gastroenterological Association; 2001."},{"key":"18_CR17","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1572-0241.2003.07296.x","volume":"98","author":"GF Longstreth","year":"2003","unstructured":"Longstreth GF, Wilson A, Knight K, et al.: Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective. Am J Gastroenterol 2003, 98:600\u2013607.","journal-title":"Am J Gastroenterol"},{"key":"18_CR18","first-page":"58","volume":"15","author":"CM Kozma","year":"2002","unstructured":"Kozma CM, Barghout V, Slaton T, et al.: Office-based physician visits: a comparison of irritable bowel syndrome with other gastrointestinal disorders using national ambulatory medical care survey data. Pract Gastroenterol 2002, 15:58\u201368.","journal-title":"Pract Gastroenterol"},{"key":"18_CR19","first-page":"40","volume":"15","author":"CM Kozma","year":"2002","unstructured":"Kozma CM, Barghout V, Slaton T, et al.: A comparison of office-based physician visits for irritable bowel syndrome and for migraine and asthma. Manag Care Interface 2002, 15:40\u201343, 49.","journal-title":"Manag Care Interface"},{"key":"18_CR20","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1185\/030079903125002540","volume":"19","author":"BC Martin","year":"2003","unstructured":"Martin BC, Ganguly R, Pannicker S, et al.: Utilization patterns and net direct medical cost to Medicaid of irritable bowel syndrome. Curr Med Res Opin 2003, 19:771\u2013780.","journal-title":"Curr Med Res Opin"},{"key":"18_CR21","first-page":"II43","volume":"45","author":"WG Thompson","year":"1999","unstructured":"Thompson WG, Longstreth GF, Drossman DA, et al.: Functional bowel disorders and functional abdominal pain. Gut 1999, 45:II43-II47.","journal-title":"Gut"},{"key":"18_CR22","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1111\/j.1572-0241.2003.07699.x","volume":"98","author":"NJ Talley","year":"2003","unstructured":"Talley NJ, Dennis EH, Schettler-Duncan VA, et al.: Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol 2003, 98:2454\u20132459.","journal-title":"Am J Gastroenterol"},{"key":"18_CR23","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/gast.2002.32392","volume":"122","author":"WE Whitehead","year":"2002","unstructured":"Whitehead WE, Palsson O, Jones KR: Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002, 122:1140\u20131156. This systematic literature review summarizes data published between 1966 and 2002 regarding the overlap between IBS and other disorders. Potential pathophysiologic similarities between overlapping disorders are discussed.","journal-title":"Gastroenterology"},{"key":"18_CR24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2036.2004.02180.x","volume":"20","author":"MD Gershon","year":"2004","unstructured":"Gershon MD: Review article: serotonin receptors and transporters \u2014roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther 2004, 20:3\u201314.","journal-title":"Aliment Pharmacol Ther"},{"key":"18_CR25","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/gast.2001.21908","volume":"120","author":"M Camilleri","year":"2001","unstructured":"Camilleri M: Management of the irritable bowel syndrome. Gastroenterology 2001, 120:652\u2013668.","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"18_CR26","first-page":"S25","volume":"3","author":"MD Gershon","year":"2003","unstructured":"Gershon MD: Serotonin and its implication for the management of irritable bowel syndrome. Rev Gastroenterol Dis 2003, 3(Suppl 2):S25-S34.","journal-title":"Rev Gastroenterol Dis"},{"key":"18_CR27","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/j.1572-0241.2004.30040.x","volume":"99","author":"M Corsetti","year":"2004","unstructured":"Corsetti M, Caenepeel P, Fischler B, et al.: Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia. Am J Gastroenterol 2004, 99:1152\u20131159.","journal-title":"Am J Gastroenterol"},{"key":"18_CR28","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0016-5085(91)90717-Y","volume":"101","author":"NJ Talley","year":"1991","unstructured":"Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ III: Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991, 101:927\u2013934.","journal-title":"Gastroenterology"},{"key":"18_CR29","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/BF01303162","volume":"38","author":"DA Drossman","year":"1993","unstructured":"Drossman DA, Li Z, Andruzzi E, et al.: U.S. householder survey of functional gastrointestinal disorders: prevalence, sociodemography, and health impact. Dig Dis Sci 1993, 38:1569\u20131580.","journal-title":"Dig Dis Sci"},{"key":"18_CR30","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0016-5085(95)90373-9","volume":"109","author":"L Agreus","year":"1995","unstructured":"Agreus L, Svardsudd K, Nyren O, Tibblin G: Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995, 109:671\u2013680.","journal-title":"Gastroenterology"},{"key":"18_CR31","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bpg.2004.04.012","volume":"18","author":"E Corazziari","year":"2004","unstructured":"Corazziari E: Definition and epidemiology of functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol 2004, 18:613\u2013631.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"18_CR32","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1016\/S0002-9270(01)03242-7","volume":"96","author":"L Agreus","year":"2001","unstructured":"Agreus L, Svardsudd K, Talley NJ, et al.: Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol 2001, 96:2905\u20132914.","journal-title":"Am J Gastroenterol"},{"key":"18_CR33","first-page":"A88","volume":"126","author":"GR Locke","year":"2004","unstructured":"Locke GR: Specific somatic symptoms associated with irritable bowel syndrome: Somatization may not be the explanation. Gastroenterology 2004, 126:A88.","journal-title":"Gastroenterology"},{"key":"18_CR34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bpg.2004.06.017","volume":"18","author":"G Holtmann","year":"2004","unstructured":"Holtmann G: IBS: a syndrome or many diseases? Best Pract Res Clin Gastroenterol 2004, 18:91\u201397.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"18_CR35","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/gast.2003.50155","volume":"124","author":"B Fischler","year":"2003","unstructured":"Fischler B, Tack J, De GV, et al.: Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia. Gastroenterology 2003, 124:903\u2013910.","journal-title":"Gastroenterology"},{"key":"18_CR36","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1365-2982.2003.00433.x","volume":"15","author":"IR Voort van der","year":"2003","unstructured":"van der Voort IR, Osmanoglou E, Seybold M, et al.: Electrogastrography as a diagnostic tool for delayed gastric emptying in functional dyspepsia and irritable bowel syndrome. Neurogastroenterol Motil 2003, 15:467\u2013473.","journal-title":"Neurogastroenterol Motil"},{"key":"18_CR37","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1136\/gut.2003.030049","volume":"53","author":"S Haag","year":"2004","unstructured":"Haag S, Talley NJ, Holtmann G: Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters. Gut 2004, 53:1445\u20131451.","journal-title":"Gut"},{"key":"18_CR38","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2982.2004.00511.x","volume":"16","author":"M Bouin","year":"2004","unstructured":"Bouin M, Lupein F, Riberdy M, et al.: Intolerance to visceral distension in functional dyspepsia or irritable bowel syndrome: an organ specific defect or a pan intestinal dysregulation? Neurogastroenterol Motil 2004, 16:311\u2013314.","journal-title":"Neurogastroenterol Motil"},{"key":"18_CR39","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1053\/gast.2002.33663","volume":"122","author":"J Tack","year":"2002","unstructured":"Tack J, Demedts I, Dehondt G, et al.: Clinical and pathophysiological characteristics of acute-onset functional dyspepsia. Gastroenterology 2002, 122:1738\u20131747.","journal-title":"Gastroenterology"},{"key":"18_CR40","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/S0016-5085(03)00324-X","volume":"124","author":"RC Spiller","year":"2003","unstructured":"Spiller RC: Postinfectious irritable bowel syndrome. Gastroenterology 2003, 124:1662\u20131671.","journal-title":"Gastroenterology"},{"key":"18_CR41","first-page":"9514","volume":"92","author":"G Holtmann","year":"1997","unstructured":"Holtmann G, Goebell H, Talley NJ: Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis? Am J Gastroenterol 1997, 92:9514\u20139519.","journal-title":"Am J Gastroenterol"},{"key":"18_CR42","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2036.2001.00941.x","volume":"15","author":"NJ Talley","year":"2001","unstructured":"Talley NJ, Van Zanten SV, Saez LR, et al.: A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia. Aliment Pharmacol Ther 2001, 15:525\u2013537.","journal-title":"Aliment Pharmacol Ther"},{"key":"18_CR43","first-page":"411","volume":"7","author":"A Carvalhinhos","year":"1995","unstructured":"Carvalhinhos A, Fidalgo P, Freire A, Matos L: Cisapride compared with ranitidine in the treatment of functional dyspepsia. Eur J Gastroenterol Hepatol 1995, 7:411\u2013417.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"18_CR44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/00365529309098328","volume":"195","author":"M Outryve Van","year":"1993","unstructured":"Van Outryve M, De Nutte N, Van Eeghem P, Gooris JP: Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind, placebo-controlled study. Scand J Gastroenterol Suppl 1993, 195:47\u201352.","journal-title":"Scand J Gastroenterol Suppl"},{"key":"18_CR45","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.bpg.2004.04.003","volume":"18","author":"F Cremonini","year":"2004","unstructured":"Cremonini F, Delgado-Aros S, Talley NJ: Functional dyspepsia: drugs for new (and old) therapeutic targets. Best Pract Res Clin Gastroenterol 2004, 18:717\u2013733.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"18_CR46","doi-asserted-by":"crossref","first-page":"A54","DOI":"10.1016\/S0016-5085(03)80265-2","volume":"124","author":"G Tougas","year":"2003","unstructured":"Tougas G, Chen Y, Luo D, et al.: Tegaserod improves gastric emptying in patients with gastroparesis and dyspeptic symptoms. Gastroenterology 2003, 124:A54.","journal-title":"Gastroenterology"},{"key":"18_CR47","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1136\/gut.52.12.1703","volume":"52","author":"JS Kalantar","year":"2003","unstructured":"Kalantar JS, Locke GR, Zinsmeister AR, et al.: Familial aggregation of irritable bowel syndrome: a prospective study. Gut 2003, 52:1703\u20131707.","journal-title":"Gut"},{"key":"18_CR48","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4065\/75.9.907","volume":"75","author":"GR III Locke","year":"2000","unstructured":"Locke GR III, Zinsmeister AR, Talley NJ, et al.: Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc 2000, 75:907\u2013912.","journal-title":"Mayo Clin Proc"},{"key":"18_CR49","first-page":"340","volume":"95","author":"NJ Talley","year":"2000","unstructured":"Talley NJ: Irritable bowel syndrome and health care seeking: do we pass our bad habits onto our children? Am J Gastroenterol 2000, 95:340\u2013341.","journal-title":"Am J Gastroenterol"},{"key":"18_CR50","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1572-0241.2004.04114.x","volume":"99","author":"PD Higgins","year":"2004","unstructured":"Higgins PD, Johanson JF: Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol 2004, 99:750\u2013759.","journal-title":"Am J Gastroenterol"},{"key":"18_CR51","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1056\/NEJMra020995","volume":"349","author":"A Lembo","year":"2003","unstructured":"Lembo A, Camilleri M: Chronic constipation. N Engl J Med 2003, 349:1360\u20131368.","journal-title":"N Engl J Med"},{"key":"18_CR52","unstructured":"Cash B, Chey WD: Update on the management of chronic constipation: what differentiates chronic constipation from IBS with constipation. Medscape Web site 2004 August 26. http:\/\/www.medscape.com\/viewarticle\/487948. Accessed November 17, 2004."},{"key":"18_CR53","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1111\/j.1572-0241.2001.05259.x","volume":"96","author":"P Pare","year":"2001","unstructured":"Pare P, Ferrazzi S, Thompson WG, et al.: An epidemiological survey of constipation in Canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol 2001, 96:3130\u20133137.","journal-title":"Am J Gastroenterol"},{"key":"18_CR54","first-page":"1","volume":"5","author":"NJ Talley","year":"2005","unstructured":"Talley NJ: Differentiating functional constipation from constipation-predominant irritable bowel syndrome: management implications. Rev Gastroenterol Dis 2005, 5:1\u20139.","journal-title":"Rev Gastroenterol Dis"},{"key":"18_CR55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2982.2004.00581.x","volume":"17","author":"GR III Locke","year":"2005","unstructured":"Locke GR III, Zinsmeister AR, Fett SL, et al.: Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil 2005, 17:29\u201334. This population-based study demonstrates the high prevalence of gastrointestinal symptom overlap in the community.","journal-title":"Neurogastroenterol Motil"},{"key":"18_CR56","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0889-8553(03)00026-8","volume":"32","author":"SS Rao","year":"2003","unstructured":"Rao SS: Constipation: evaluation and treatment. Gastroenterol Clin North Am 2003, 32:659\u2013683.","journal-title":"Gastroenterol Clin North Am"},{"key":"18_CR57","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000075554","volume":"68","author":"G Bassotti","year":"2003","unstructured":"Bassotti G, Chistolini F, Marinozzi G, Morelli A: Abnormal colonic propagated activity in patients with slow transit constipation and constipation-predominant irritable bowel syndrome. Digestion 2003, 68:178\u2013183.","journal-title":"Digestion"},{"key":"18_CR58","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/003655299750025110","volume":"34","author":"Salhy M El","year":"1999","unstructured":"El Salhy M, Norrgard O, Spinnell S: Abnormal colonic endocrine cells in patients with chronic idiopathic slow-transit constipation. Scand J Gastroenterol 1999, 34:1007\u20131011.","journal-title":"Scand J Gastroenterol"},{"key":"18_CR59","first-page":"24","volume":"49","author":"S Rossi","year":"2003","unstructured":"Rossi S, Choudhary C: Medical treatment and clinical course of gastroesophageal reflux disease. Resid Staff Physician 2003, 49:24\u201328.","journal-title":"Resid Staff Physician"},{"key":"18_CR60","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/bmj.326.7392.737","volume":"326","author":"A Raghunath","year":"2003","unstructured":"Raghunath A, Hungin AP, Wooff D, Childs S: Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 2003, 326:737.","journal-title":"BMJ"},{"key":"18_CR61","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00004836-200203000-00004","volume":"34","author":"M Pimentel","year":"2002","unstructured":"Pimentel M, Rossi F, Chow EJ, et al.: Increased prevalence of irritable bowel syndrome in patients with gastroesophageal reflux. J Clin Gastroenterol 2002, 34:221\u2013224.","journal-title":"J Clin Gastroenterol"},{"key":"18_CR62","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jpain.2003.12.004","volume":"5","author":"A Berger","year":"2004","unstructured":"Berger A, Dukes EM, Oster G: Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain 2004, 5:143\u2013149.","journal-title":"J Pain"},{"key":"18_CR63","first-page":"1311","volume":"68","author":"JJ Heidelbaugh","year":"2003","unstructured":"Heidelbaugh JJ, Nostrant TT, Kim C, Van Harrison R: Management of gastroesophageal reflux disease. Am Fam Physician 2003, 68:1311\u20131318.","journal-title":"Am Fam Physician"},{"key":"18_CR64","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/gut.43.6.770","volume":"43","author":"TM Kennedy","year":"1998","unstructured":"Kennedy TM, Jones RH, Hungin AP, et al.: Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population. Gut 1998, 43:770\u2013774.","journal-title":"Gut"},{"key":"18_CR65","first-page":"1003","volume":"89","author":"S Lin","year":"1994","unstructured":"Lin S, Ke M, Xu J, Kahrilas PJ: Impaired esophageal emptying in reflux disease. Am J Gastroenterol 1994, 89:1003\u20136.","journal-title":"Am J Gastroenterol"},{"key":"18_CR66","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1046\/j.1365-2036.2000.00854.x","volume":"14","author":"PJ Kahrilas","year":"2000","unstructured":"Kahrilas PJ, Quigley EM, Castell DO, Spechler SJ: The effects of tegaserod (HTF 919) on esophageal acid exposure in gastroesophageal reflux disease. Aliment Pharmacol Ther 2000, 14:1503\u20131509.","journal-title":"Aliment Pharmacol Ther"},{"key":"18_CR67","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/j.gastro.2004.05.008","volume":"127","author":"S Rodriguez-Stanley","year":"2004","unstructured":"Rodriguez-Stanley S, Zubaidi S, Wolff M, et al.: Tegaserod significantly improves esophageal mechanical pain threshold, regurgitation and global preference vs placebo in patients with functional heartburn. Gastroenterology 2004, 127:331\u2013333.","journal-title":"Gastroenterology"},{"key":"18_CR68","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1111\/j.1572-0241.2003.07699.x","volume":"98","author":"NJ Talley","year":"2003","unstructured":"Talley NJ, Dennis EH, Schettler-Duncan VA, et al.: Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterology 2003, 98:2454\u20132459.","journal-title":"Am J Gastroenterology"},{"key":"18_CR69","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bpg.2004.04.012","volume":"18","author":"E Corazziari","year":"2004","unstructured":"Corazziari E: Definition and epidemiology of functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol 2004, 18:613\u2013631.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"18_CR70","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1056\/NEJMra010852","volume":"346","author":"RJ Farrell","year":"2002","unstructured":"Farrell RJ, Kelly CP: Celiac sprue. N Engl J Med 2002, 346:180\u2013188.","journal-title":"N Engl J Med"},{"key":"18_CR71","first-page":"2259","volume":"66","author":"DA Nelsen Jr","year":"2002","unstructured":"Nelsen DA Jr: Gluten-sensitive enteropathy (celiac disease): more common than you think. Am Fam Physician 2002, 66:2259\u20132266.","journal-title":"Am Fam Physician"},{"issue":"Suppl 2","key":"18_CR72","first-page":"ii1","volume":"47","author":"J Jones","year":"2000","unstructured":"Jones J, Boorman J, Cann P, et al.: British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut 2000, 47(Suppl 2):ii1-ii19.","journal-title":"Gut"},{"key":"18_CR73","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-2036.2003.01666.x","volume":"18","author":"B Shahbazkhani","year":"2003","unstructured":"Shahbazkhani B, Forootan M, Merat S, et al.: Coeliac disease presenting with symptoms of irritable bowel syndrome. Aliment Pharmacol Ther 2003, 18:231\u2013235.","journal-title":"Aliment Pharmacol Ther"},{"key":"18_CR74","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/j.1572-0241.2002.05690.x","volume":"97","author":"C O\u2019Leary","year":"2002","unstructured":"O\u2019Leary C, Wieneke P, Buckley S, et al.: Celiac disease and irritable bowel-type symptoms. Am J Gastroenterol 2002, 97:1463\u20131467.","journal-title":"Am J Gastroenterol"},{"key":"18_CR75","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0140-6736(01)06581-3","volume":"358","author":"DS Sanders","year":"2001","unstructured":"Sanders DS, Carter MJ, Hurlstone DP, et al.: Association of adult coeliac disease with irritable bowel syndrome: a casecontrol study in patients fulfilling ROME II criteria referred to secondary care. Lancet 2001, 358:1504\u20131508.","journal-title":"Lancet"},{"key":"18_CR76","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1053\/gast.2001.29572","volume":"121","author":"U Wahnschaffe","year":"2001","unstructured":"Wahnschaffe U, Ullrich R, Riecken EO, Schulzke JD: Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome. Gastroenterology 2001, 121:1329\u20131338.","journal-title":"Gastroenterology"},{"key":"18_CR77","doi-asserted-by":"crossref","first-page":"476","DOI":"10.4065\/79.4.476","volume":"79","author":"GR III Locke","year":"2004","unstructured":"Locke GR III, Murray JA, Zinsmeister AR, et al.: Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study. Mayo Clin Proc 2004, 79:476\u2013482.","journal-title":"Mayo Clin Proc"},{"key":"18_CR78","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1111\/j.1572-0241.1998.00531.x","volume":"93","author":"AM Niec","year":"1998","unstructured":"Niec AM, Frankum B, Talley NJ: Are adverse food reactions linked to irritable bowel syndrome? Am J Gastroenterol 1998, 93:2184\u20132190.","journal-title":"Am J Gastroenterol"},{"key":"18_CR79","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1111\/j.1572-0241.2003.08670.x","volume":"98","author":"M Pimentel","year":"2003","unstructured":"Pimentel M, Kong Y, Park S: Breath testing to evaluate lactose intolerance in irritable bowel syndrome correlates with lactulose testing and may not reflect true lactose malabsorption. Am J Gastroenterol 2003, 98:2700\u20132704.","journal-title":"Am J Gastroenterol"},{"key":"18_CR80","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00004836-199904000-00005","volume":"28","author":"AD Shaw","year":"1999","unstructured":"Shaw AD, Davies GJ: Lactose intolerance: problems in diagnosis and treatment. J Clin Gastroenterol 1999, 28:208\u2013216.","journal-title":"J Clin Gastroenterol"},{"key":"18_CR81","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1080\/00365520410009627","volume":"39","author":"R Montes","year":"2004","unstructured":"Montes R, Monge E: Lactose malabsorption and IBS [letter]. Scand J Gastroenterol 2004, 39:1033.","journal-title":"Scand J Gastroenterol"},{"key":"18_CR82","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/00365520410005405","volume":"39","author":"PG Farup","year":"2004","unstructured":"Farup PG, Monsbakken KW, Vandvik PO: Lactose malabsorption in a population with irritable bowel syndrome: prevalence and symptoms. A case-control study. Scand J Gastroenterol 2004, 39:645\u2013649.","journal-title":"Scand J Gastroenterol"},{"key":"18_CR83","doi-asserted-by":"crossref","first-page":"868","DOI":"10.7326\/0003-4819-134-9_Part_2-200105011-00011","volume":"134","author":"LA Aaron","year":"2001","unstructured":"Aaron LA, Buchwald D: A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med 2001, 134:868\u2013881.","journal-title":"Ann Intern Med"},{"key":"18_CR84","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s00296-003-0328-x","volume":"24","author":"S Akkus","year":"2004","unstructured":"Akkus S, Senol A, Ayvacioglu NB, et al.: Is female predominance in irritable bowel syndrome related to fibromyalgia? Rheumatol Int 2004, 24:106\u2013109.","journal-title":"Rheumatol Int"},{"key":"18_CR85","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11916-996-0009-z","volume":"8","author":"DJ Wallace","year":"2004","unstructured":"Wallace DJ, Hallegua DS: Fibromyalgia: the gastrointestinal link. Curr Pain Headache Rep 2004, 8:364\u2013368.","journal-title":"Curr Pain Headache Rep"},{"key":"18_CR86","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1111\/j.1572-0241.1999.01643.x","volume":"94","author":"AD Sperber","year":"1999","unstructured":"Sperber AD, Atzmon Y, Neumann L, et al.: Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. Am J Gastroenterol 1999, 94:3541\u20133546.","journal-title":"Am J Gastroenterol"},{"key":"18_CR87","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/j.1365-2036.2004.02250.x","volume":"20","author":"PO Vandvik","year":"2004","unstructured":"Vandvik PO, Wilhelmsen I, Ihlebaek C, Farup PG: Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Aliment Pharmacol Ther 2004, 20:1195\u20131203.","journal-title":"Aliment Pharmacol Ther"},{"key":"18_CR88","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/j.1572-0241.2003.07478.x","volume":"98","author":"L Chang","year":"2003","unstructured":"Chang L, Berman S, Mayer EA, et al.: Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and without fibromyalgia. Am J Gastroenterol 2003, 98:1354\u20131361.","journal-title":"Am J Gastroenterol"},{"key":"18_CR89","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0304-3959(99)00215-8","volume":"84","author":"L Chang","year":"2000","unstructured":"Chang L, Mayer EA, Johnson T, et al.: Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia. Pain 2000, 84:297\u2013307.","journal-title":"Pain"},{"key":"18_CR90","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/ard.2003.011502","volume":"63","author":"M Pimentel","year":"2004","unstructured":"Pimentel M, Wallace D, Hallegua D, et al.: A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann Rheum Dis 2004, 63:450\u2013452.","journal-title":"Ann Rheum Dis"},{"key":"18_CR91","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJMicm010380","volume":"346","author":"JM Dominguez","year":"2002","unstructured":"Dominguez JM, Serri K: Image in clinical medicine. Disseminated histoplasmosis in a patient with human immunodeficiency virus infection. N Engl J Med 2002, 346:2061.","journal-title":"N Engl J Med"},{"key":"18_CR92","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/01.AOG.0000135275.63494.3d","volume":"104","author":"RE Williams","year":"2004","unstructured":"Williams RE, Hartmann KE, Sandler RS, et al.: Prevalence and characteristics of irritable bowel syndrome among women with chronic pelvic pain. Obstet Gynecol 2004, 104:452\u2013458.","journal-title":"Obstet Gynecol"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-005-0018-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-005-0018-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-005-0018-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:03:52Z","timestamp":1559433832000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-005-0018-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":92,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["18"],"URL":"https:\/\/doi.org\/10.1007\/s11894-005-0018-9","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}